Skip to main content

Page of 2 next disabled
and
  1. Article

    Erratum to: The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation

    Stefan Kölker, Angeles Garcia Cazorla in Journal of Inherited Metabolic Disease (2015)

  2. Article

    Quo vadis: the re-definition of “inborn metabolic diseases”

    Eva Morava, Shamima Rahman, Verena Peters in Journal of Inherited Metabolic Disease (2015)

  3. Article

    Erratum to: The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype

    Stefan Kölker, Vassili Valayannopoulos in Journal of Inherited Metabolic Disease (2015)

  4. No Access

    Article

    The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation

    The clinical presentation of patients with organic acidurias (OAD) and urea cycle disorders (UCD) is variable; symptoms are often non-specific.

    Stefan Kölker, Angeles Garcia Cazorla in Journal of Inherited Metabolic Disease (2015)

  5. Article

    Open Access

    Newborn screening for homocystinurias and methylation disorders: systematic review and proposed guidelines

    Newborn screening (NBS) is justified if early intervention is effective in a disorder generally not detected early in life on a clinical basis, and if sensitive and specific biochemical markers exist. Experien...

    Martina Huemer, Viktor Kožich, Piero Rinaldo in Journal of Inherited Metabolic Disease (2015)

  6. No Access

    Article

    The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype

    The disease course and long-term outcome of patients with organic acidurias (OAD) and urea cycle disorders (UCD) are incompletely understood.

    Stefan Kölker, Vassili Valayannopoulos in Journal of Inherited Metabolic Disease (2015)

  7. Article

    Complex lipids

    Jean-Marie Saudubray, Matthias R. Baumgartner in Journal of Inherited Metabolic Disease (2015)

  8. No Access

    Chapter

    Networking Across Borders for Individuals with Organic Acidurias and Urea Cycle Disorders: The E-IMD Consortium

    Background: Patients with organic acidurias (OAD) and urea cycle disorders (UCD) are at increased risk of disability, impaired quality of life and reduced life expectancy. Clinical care in any one ...

    Stefan Kölker, Dries Dobbelaere, Johannes Häberle, Peter Burgard in JIMD Reports, Volume 22 (2015)

  9. No Access

    Article

    Characterization of functional domains of the cblD (MMADHC) gene product

    In humans vitamin B12 (cobalamin, Cbl) must be converted into two coenzyme forms, methylcobalamin (MeCbl) and adenosylcobalamin (AdoCbl), in order to maintain intracellular homeostasis of homocysteine and methylm...

    Jehona Jusufi, Terttu Suormala, Patricie Burda in Journal of Inherited Metabolic Disease (2014)

  10. No Access

    Chapter

    Vitamin B12 Disorders

    Vitamin B12 (Cbl) is needed for just two metabolic reactions in man, the methylation of homocysteine to methionine (cofactor methyl-Cbl) and the conversion of methylmalonyl-CoA to succinyl-CoA (cofactor adenosyl-...

    Matthias R. Baumgartner, Brian Fowler in Physician's Guide to the Diagnosis, Treatm… (2014)

  11. Article

    Open Access

    Cross-sectional observational study of 208 patients with non-classical urea cycle disorders

    Urea cycle disorders (UCDs) are inherited disorders of ammonia detoxification often regarded as mainly of relevance to pediatricians. Based on an increasing number of case studies it has become obvious that a ...

    Corinne M. Rüegger, Martin Lindner in Journal of Inherited Metabolic Disease (2014)

  12. No Access

    Article

    Understanding pyrroline-5-carboxylate synthetase deficiency: clinical, molecular, functional, and expression studies, structure-based analysis, and novel therapy with arginine

    Δ1-Pyrroline-5-carboxylate synthetase (P5CS) catalyzes the first two steps of ornithine/proline biosynthesis. P5CS deficiency has been reported in three families, with patients presenting with cutis/joint laxity....

    Diego Martinelli, Johannes Häberle, Vicente Rubio in Journal of Inherited Metabolic Disease (2012)

  13. No Access

    Chapter

    Biotin-responsive Disorders

    Two inherited defects affecting the coenzyme function of biotin are known: holocarboxylase synthetase (HCS) deficiency and biotinidase deficiency. Both lead to deficiency of all biotin-dependent carboxylases, i.e...

    Matthias R. Baumgartner, Terttu Suormala in Inborn Metabolic Diseases (2012)

  14. No Access

    Chapter

    Disorders of Ornithine Metabolism

    Hyperornithinaemia due to ornithine aminotransferase (OAT) deficiency results in gyrate atrophy of the choroid and retina (GA). Although the progression of the retinal degeneration is highly variab...

    Matthias R. Baumgartner, David Valle in Inborn Metabolic Diseases (2012)

  15. No Access

    Article

    CRIM-negative infantile Pompe disease: 42-month treatment outcome

    Pompe disease is a rare lysosomal glycogen storage disorder characterized by deficiency of acid α-glucosidase enzyme (GAA) and caused by mutations in the GAA gene. Infantile-type Pompe disease is a multiorgan dis...

    Marianne Rohrbach, Andrea Klein in Journal of Inherited Metabolic Disease (2010)

  16. No Access

    Article

    Postprandial changes of amino acid and acylcarnitine concentrations in dried blood samples

    Blood sampling for newborn screening cannot be standardized as for example blood collection in adults after an overnight fast. Therefore the influence of postprandial changes and individual variation is valuab...

    Ralph Fingerhut, Gabriel De Jesus Silva Arevalo in Journal of Inherited Metabolic Disease (2010)

  17. No Access

    Chapter

    Biotin-Responsive Disorders

    Two inherited defects in biotin metabolism are known: holocarboxylase synthetase (HCS) deficiency and biotinidase deficiency. Both lead to deficiency of all biotindependent carboxylases, i.e. to multiple carboxyl...

    Matthias R. Baumgartner, Terttu Suormala in Inborn Metabolic Diseases (2006)

  18. No Access

    Chapter

    Disorders of Ornithine Metabolism

    Hyperornithinemia due to ornithine aminotransferase (OAT) deficiency is associated with gyrate atrophy of the choroid and retina. Patients usually become virtually blind by age 55. Treatment...

    Vivian E. Shih, Matthias R. Baumgartner in Inborn Metabolic Diseases (2006)

Page of 2 next disabled